Review: taking Neurontin and Butrans together


Summary

Drug interactions are reported among people who take Neurontin and Butrans together. This review analyzes the effectiveness and drug interactions between Neurontin and Butrans. It is created by eHealthMe based on reports of 413 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Neurontin and Butrans >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Neurontin

Neurontin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Neurontin 63,468 users)

Butrans

Butrans has active ingredients of buprenorphine. It is often used in pain. (latest outcomes from Butrans 14,109 users)

On Aug, 19, 2016

413 people who take Neurontin, Butrans are studied.


Number of reports submitted per year:

Neurontin and Butrans drug interactions.

Drug effectiveness over time:

Neurontin:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 5 people)
  • 6 - 12 months: 0.0% - (0 of 3 people)
  • 1 - 2 years: 25.0% - (1 of 4 people)
  • 2 - 5 years: 50.0% - (2 of 4 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Butrans:
  • < 1 month: 33.0% - (1 of 3 people)
  • 1 - 6 months: 57.0% - (4 of 7 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 80.0% - (4 of 5 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Neurontin:
  • female: 20.0% - (2 of 10 people)
  • male: 10.0% - (1 of 10 people)
Butrans:
  • female: 54.0% - (6 of 11 people)
  • male: 60.0% - (6 of 10 people)

Drug effectiveness by age:

Neurontin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 2 people)
  • 30-39: 0.0% - (0 of 3 people)
  • 40-49: 14.0% - (1 of 7 people)
  • 50-59: 20.0% - (1 of 5 people)
  • 60+: 33.0% - (1 of 3 people)
Butrans:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (1 of 2 people)
  • 30-39: 75.0% - (3 of 4 people)
  • 40-49: 50.0% - (3 of 6 people)
  • 50-59: 60.0% - (3 of 5 people)
  • 60+: 50.0% - (2 of 4 people)

Most common drug interactions over time *:

< 1 month:
  • dizziness
  • pain
  • drug ineffective
  • confusional state
  • malignant neoplasm progression
  • somnolence
  • insomnia
  • headache
  • anxiety
  • application site pruritus
1 - 6 months:
  • premature delivery
  • pain
  • premature labour
  • paraesthesia
  • hypoaesthesia
  • sleep walking
  • application site erythema
  • disturbance in attention
  • drug withdrawal syndrome
  • fall
6 - 12 months:
  • foetal exposure during pregnancy
  • anxiety
  • drug withdrawal syndrome neonatal
  • feeding disorder neonatal
  • low birth weight baby
  • sweating - excessive
  • anger
  • blood glucose abnormal
  • chills
  • cough
1 - 2 years:
  • congenital diaphragmatic hernia
  • depression
  • fatigue
  • foetal exposure during pregnancy
  • hypertension
  • insomnia
  • premature baby
  • affect lability
  • anger
  • anhedonia
2 - 5 years:
  • confusional state
  • sweating - excessive
  • anxiety
  • back pain - low
  • coagulation factor v level decreased
  • hepatic encephalopathy
  • hepatic failure
  • chills
  • oedema
  • pyrexia
5 - 10 years:
  • fatigue
10+ years:
  • back pain - low
  • cognitive disorder
  • deep vein thrombosis
  • ischaemic stroke
not specified:
  • dizziness
  • pain
  • nausea
  • vomiting
  • anxiety
  • insomnia
  • pyrexia
  • diarrhoea
  • fall
  • eye pain

Most common drug interactions by gender *:

female:
  • dizziness
  • pain
  • nausea
  • vomiting
  • anxiety
  • insomnia
  • diarrhoea
  • pyrexia
  • fall
  • hypoaesthesia
male:
  • drug withdrawal syndrome
  • depression
  • nausea
  • headache
  • paraesthesia
  • vomiting
  • dehydration
  • corneal ulcer
  • hyperbilirubinaemia
  • keratitis

Most common drug interactions by age *:

0-1:
  • atrial septal defect
  • small for dates baby
  • ventricular septal defect
10-19:
  • cardiac arrest
  • cardiac failure
  • pleural effusion
20-29:
  • dizziness
  • hypoaesthesia
  • application site rash
  • hypersensitivity
  • loss of consciousness
  • throat tightness
  • urticaria
  • abnormal dreams
  • arthralgia
  • cerebrovascular accident
30-39:
  • headache
  • depression
  • corneal ulcer
  • hyperbilirubinaemia
  • keratitis
  • paraesthesia
  • eyelid ptosis
  • oral candidiasis
  • scab
  • bronchitis
40-49:
  • depression
  • dizziness
  • drug withdrawal syndrome
  • asthenia
  • cardiac arrest
  • nausea
  • respiratory arrest
  • vomiting
  • ankle fracture
  • anxiety
50-59:
  • insomnia
  • dizziness
  • anxiety
  • pain
  • hypoaesthesia
  • emotional distress
  • fall
  • accidental overdose
  • arthralgia
  • bone disorder
60+:
  • nausea
  • vomiting
  • somnolence
  • dehydration
  • pain
  • anaemia
  • pneumonia aspiration
  • dizziness
  • asthenia
  • diarrhoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Neurontin and Butrans?

Can you answer these questions?

More questions for: Neurontin, Butrans

You may be interested in these reviews

More reviews for: Neurontin, Butrans

On eHealthMe, Neurontin (gabapentin) is often used to treat pain. Butrans (buprenorphine) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.